Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Targeted Cancer Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Targeted Cancer Drugs are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Targeted Cancer Drugs market segmented into
Cancer Growth Blocker Drug
Monoclonal Antibody
Other
Based on the end-use, the global Targeted Cancer Drugs market classified into
Hospitals
Academic & Research Institutes
Diagnostic & Reference Laboratories
Based on geography, the global Targeted Cancer Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TARGETED CANCER DRUGS INDUSTRY
2.1 Summary about Targeted Cancer Drugs Industry
2.2 Targeted Cancer Drugs Market Trends
2.2.1 Targeted Cancer Drugs Production & Consumption Trends
2.2.2 Targeted Cancer Drugs Demand Structure Trends
2.3 Targeted Cancer Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cancer Growth Blocker Drug
4.2.2 Monoclonal Antibody
4.2.3 Other
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Academic & Research Institutes
4.3.3 Diagnostic & Reference Laboratories
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cancer Growth Blocker Drug
5.2.2 Monoclonal Antibody
5.2.3 Other
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Academic & Research Institutes
5.3.3 Diagnostic & Reference Laboratories
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cancer Growth Blocker Drug
6.2.2 Monoclonal Antibody
6.2.3 Other
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Academic & Research Institutes
6.3.3 Diagnostic & Reference Laboratories
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cancer Growth Blocker Drug
7.2.2 Monoclonal Antibody
7.2.3 Other
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Academic & Research Institutes
7.3.3 Diagnostic & Reference Laboratories
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cancer Growth Blocker Drug
8.2.2 Monoclonal Antibody
8.2.3 Other
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Academic & Research Institutes
8.3.3 Diagnostic & Reference Laboratories
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cancer Growth Blocker Drug
9.2.2 Monoclonal Antibody
9.2.3 Other
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Academic & Research Institutes
9.3.3 Diagnostic & Reference Laboratories
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer
10.1.2 Incyte
10.1.3 Novartis
10.1.4 Eli Lilly
10.1.5 Gilead
10.1.6 Sanofi
10.1.7 Galapagos
10.1.8 AbbVie
10.1.9 Vertex
10.1.10 Teva
10.1.11 Astellas Pharma
10.1.12 Celgene
10.2 Targeted Cancer Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer
10.2.2 Incyte
10.2.3 Novartis
10.2.4 Eli Lilly
10.2.5 Gilead
10.2.6 Sanofi
10.2.7 Galapagos
10.2.8 AbbVie
10.2.9 Vertex
10.2.10 Teva
10.2.11 Astellas Pharma
10.2.12 Celgene
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Targeted Cancer Drugs Product Type Overview
Table Targeted Cancer Drugs Product Type Market Share List
Table Targeted Cancer Drugs Product Type of Major Players
Table Brief Introduction of Pfizer
Table Brief Introduction of Incyte
Table Brief Introduction of Novartis
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Gilead
Table Brief Introduction of Sanofi
Table Brief Introduction of Galapagos
Table Brief Introduction of AbbVie
Table Brief Introduction of Vertex
Table Brief Introduction of Teva
Table Brief Introduction of Astellas Pharma
Table Brief Introduction of Celgene
Table Products & Services of Pfizer
Table Products & Services of Incyte
Table Products & Services of Novartis
Table Products & Services of Eli Lilly
Table Products & Services of Gilead
Table Products & Services of Sanofi
Table Products & Services of Galapagos
Table Products & Services of AbbVie
Table Products & Services of Vertex
Table Products & Services of Teva
Table Products & Services of Astellas Pharma
Table Products & Services of Celgene
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Targeted Cancer Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Targeted Cancer Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Targeted Cancer Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Targeted Cancer Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Targeted Cancer Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Targeted Cancer Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Targeted Cancer Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Targeted Cancer Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Targeted Cancer Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Targeted Cancer Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Targeted Cancer Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer Growth Blocker Drug Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibody Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Academic & Research Institutes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic & Reference Laboratories Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Incyte 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Gilead 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Galapagos 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of AbbVie 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Vertex 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Teva 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Astellas Pharma 2017-2020e
Figure Targeted Cancer Drugs Sales Revenue (Million USD) of Celgene 2017-2020e
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
The Targeted Protein Degradation Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Advanced Cancer Care Coordination Market:
The report discusses everything a marketer requires before investing in the global Advanced Cancer Care Coordination Market during the forecast period...
Overview of the Global Online Cancer Patient Registry Software Market:
The report discusses everything a marketer requires before investing in the global Online Cancer Patient Registry Software Market during the for...
Overview of the Global Cancer Pain Management Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Pain Management Software Market during the forecast period 202...
Overview of the Global Holistic Mindfulness Cancer Care Management Market:
The report discusses everything a marketer requires before investing in the global Holistic Mindfulness Cancer Care Management Market during...
Overview of the Global Cancer Registry Management Solutions Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Management Solutions Market during the forecast ...
Overview of the Global Cancer Registry Quality Control Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Quality Control Software Market during the f...
Overview of the Global Early Cancer Screening Technologies Market:
The report discusses everything a marketer requires before investing in the global Early Cancer Screening Technologies Market during the forecast pe...